title: Reply to letter from Kopjar et al.-the IMPACT-CABG Pilot Trial.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Noiseux
authors.forename: Louis-Mathieu
authors.initials: LM
authors.lastname: Stevens
authors.forename: Ignacio
authors.initials: I
authors.lastname: Prieto
authors.forename: Reda
authors.initials: R
authors.lastname: Salem
authors.forename: Denis-Claude
authors.initials: DC
authors.lastname: Roy
authors.forename: Eric
authors.initials: E
authors.lastname: Larose
authors.forename: Samer
authors.initials: S
authors.lastname: Mansour
mesh_terms: D015703:Antigens, CD; D001026:Coronary Artery Bypass; D006023:Glycoproteins; D006801:Humans; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation; D017202:Myocardial Ischemia / Q000601:surgery*; D009206:Myocardium / Q000473:pathology*; D010455:Peptides
chemical_list: D015703:Antigens, CD; D006023:Glycoproteins; D010455:Peptides